Cytogen (Korea) Market Value
| 217330 Stock | KRW 6,820 320.00 4.48% |
| Symbol | Cytogen |
Cytogen 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cytogen's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cytogen.
| 11/01/2024 |
| 12/01/2024 |
If you would invest 0.00 in Cytogen on November 1, 2024 and sell it all today you would earn a total of 0.00 from holding Cytogen or generate 0.0% return on investment in Cytogen over 30 days. Cytogen is related to or competes with Kukdo Chemical, LG Chemicals, Aprogen Healthcare, Kakao Games, CJ Seafood, Seoul Food, and Sam Yang. Cytogen, Inc., a biotechnology company, develops and sells CTC enrichment and downstream systems to treat cancer in Sout... More
Cytogen Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cytogen's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cytogen upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 16.92 | |||
| Value At Risk | (4.54) | |||
| Potential Upside | 5.61 |
Cytogen Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cytogen's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cytogen's standard deviation. In reality, there are many statistical measures that can use Cytogen historical prices to predict the future Cytogen's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | 0.1025 | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | 0.0513 |
Cytogen Backtested Returns
Cytogen secures Sharpe Ratio (or Efficiency) of -0.028, which signifies that the company had a -0.028% return per unit of risk over the last 3 months. Cytogen exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cytogen's Mean Deviation of 2.45, standard deviation of 3.19, and Risk Adjusted Performance of (0.01) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.34, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Cytogen are expected to decrease by larger amounts. On the other hand, during market turmoil, Cytogen is expected to outperform it. At this point, Cytogen has a negative expected return of -0.0908%. Please make sure to confirm Cytogen's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if Cytogen performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.40 |
Average predictability
Cytogen has average predictability. Overlapping area represents the amount of predictability between Cytogen time series from 1st of November 2024 to 16th of November 2024 and 16th of November 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cytogen price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Cytogen price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 76 K |
Cytogen lagged returns against current returns
Autocorrelation, which is Cytogen stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cytogen's stock expected returns. We can calculate the autocorrelation of Cytogen returns to help us make a trade decision. For example, suppose you find that Cytogen has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cytogen regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cytogen stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cytogen stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cytogen stock over time.
Current vs Lagged Prices |
| Timeline |
Cytogen Lagged Returns
When evaluating Cytogen's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cytogen stock have on its future price. Cytogen autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cytogen autocorrelation shows the relationship between Cytogen stock current value and its past values and can show if there is a momentum factor associated with investing in Cytogen.
Regressed Prices |
| Timeline |
Pair Trading with Cytogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytogen will appreciate offsetting losses from the drop in the long position's value.Moving against Cytogen Stock
The ability to find closely correlated positions to Cytogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytogen to buy it.
The correlation of Cytogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Cytogen Stock
Cytogen financial ratios help investors to determine whether Cytogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cytogen with respect to the benefits of owning Cytogen security.